From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states

2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2017; 103(3). http://www.sciencedirect.com/science/article/pii/S0003497516317659

Title: 2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
Publication: Ann Thorac Surg
Publication Date: 2017
Volume & Issue: Volume 103, Issue 3
Pages: 102-35
URL: Read Full Resource

Improvements in QoL from TAVR in SAS patients
Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)… [ Get More Details ]
From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
[ Get More Details ]
TAVR Procedures 2011 – 2015
From approval in 2011 through 2015, >54,000 transcatheter aortic valve replacements (TAVRs) were performed in 418 centers in 48 states. [ Get More Details ]
TAVR v. SAVR in Intermediate-Risk SAS Patients
At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical… [ Get More Details ]
Cost-effectiveness of TAVR in sSAS patients
Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY… [ Get More Details ]